bosentan anhydrous has been researched along with Injury, Myocardial Reperfusion in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 10 (71.43) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, MH; Irwin, MG; Lei, S; Liu, HM; Liu, KX; Liu, Y; Xia, Z | 1 |
| Bröijersén, A; Erbas, D; Gonon, AT; Pernow, J; Valen, G | 1 |
| Bröijersén, A; Bulhak, A; Gonon, AT; Pernow, J | 1 |
| Ansley, DM; Kuo, KH; McNeill, JH; Xia, Z | 1 |
| Arya, DS; Gupta, SK; Saxena, A; Singh, U | 1 |
| Amit, S; Kumar, OS; Mukesh, N; Rajan, M; Singh, AD | 1 |
| Hampton, MB; Keenan, JI; Kerkelä, R; Pemberton, CJ; Piuhola, J; Richards, AM | 1 |
| Li, XS; Lundberg, JM; Pernow, J; Wang, QD | 1 |
| Blanc, T; Hogie, M; Kaeffer, N; Richard, V; Thuillez, C; Tron, C | 1 |
| Amrani, M; Chester, AH; Goodwin, AT; Gray, CC; Yacoub, MH | 1 |
| Allegrini, PR; Buser, PT; Hornstein, PS; Zaugg, CE; Zhu, P | 1 |
| Duffy, JY; Lombardi, JP; Nelson, DP; Pearl, JM; Wagner, CJ | 1 |
| Amrani, M; Goodwin, AT; Gray, CC; Jayakumar, J; Smolenski, RT; Yacoub, MH | 1 |
| Fedak, PW; Ko, L; Li, RK; Li, SH; Maitland, A; Mickle, DA; Pomroy, NC; Rao, V; Verma, S; Weisel, RD | 1 |
14 other study(ies) available for bosentan anhydrous and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Bosentan affects 15-F2t-isoprostane adverse effects on postischemic rat hearts.
Topics: Animals; Bosentan; Creatine Kinase; Dinoprost; Endothelin Receptor Antagonists; Endothelin-1; Heart; Isoprostanes; Male; Models, Animal; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Sprague-Dawley; Sulfonamides | 2011 |
Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion.
Topics: Adenosine Diphosphate; Animals; Bosentan; Cardiotonic Agents; Coronary Circulation; Endothelin Receptor Antagonists; Enzyme Inhibitors; Hemodynamics; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitroprusside; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Sulfonamides; Vasodilator Agents | 2004 |
Cardioprotective effect of an endothelin receptor antagonist during ischaemia/reperfusion in the severely atherosclerotic mouse heart.
Topics: Animals; Arteriosclerosis; Bosentan; Cardiotonic Agents; Coronary Circulation; Endothelin Receptor Antagonists; Fibrosis; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide Synthase; Reperfusion; Sulfonamides | 2005 |
Endothelin A and B receptor antagonist bosentan reduces postischemic myocardial injury in the rat: critical timing of administration.
Topics: Animals; Bosentan; Creatine Kinase; Creatine Kinase, MB Form; Drug Administration Schedule; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Heart; Isoenzymes; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rats; Sulfonamides; Time Factors; Ventricular Pressure | 2005 |
Bosentan, the mixed ETA-ETB endothelin receptor antagonist, attenuated oxidative stress after experimental myocardial ischemia and reperfusion.
Topics: Animals; Bosentan; Cardiotonic Agents; Catalase; Endothelin Receptor Antagonists; Glutathione; Male; Malondialdehyde; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Oxidative Stress; Rats; Rats, Wistar; Sulfonamides; Superoxide Dismutase | 2005 |
Cardioprotective effects of bosentan, a mixed endothelin type A and B receptor antagonist, during myocardial ischaemia and reperfusion in rats.
Topics: Animals; Blood Pressure; Bosentan; Cardiotonic Agents; Creatine Kinase; Diastole; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Heart Rate; Male; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Wistar; Sulfonamides; Survival Analysis; Systole; Time Factors | 2006 |
Direct cardiac actions of erythropoietin (EPO): effects on cardiac contractility, BNP secretion and ischaemia/reperfusion injury.
Topics: Animals; Apoptosis; Bosentan; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Erythropoietin; Heart; Humans; Janus Kinase 2; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Natriuretic Peptide, Brain; Perfusion; Phosphorylation; Rats; Rats, Sprague-Dawley; Recombinant Proteins; STAT3 Transcription Factor; Stimulation, Chemical; Sulfonamides | 2008 |
Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischaemic and reperfusion injury in the pig.
Topics: Animals; Blood Pressure; Bosentan; Coronary Vessels; Endothelin Receptor Antagonists; Endothelins; Female; Heart Rate; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Regional Blood Flow; Serotonin; Sulfonamides; Swine; Vasoconstriction | 1995 |
Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist.
Topics: Animals; Blood Pressure; Bosentan; Coronary Vessels; Endothelin Receptor Antagonists; Endothelins; Endothelium, Vascular; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Wistar; Sulfonamides; Ventricular Fibrillation | 1994 |
Inhibition of endogenous endothelin during cardioplegia improves low coronary reflow following prolonged hypothermic arrest.
Topics: Animals; Bicarbonates; Bosentan; Calcium Chloride; Cardioplegic Solutions; Coronary Circulation; Endothelin Receptor Antagonists; Endothelin-1; Glycopeptides; Heart Arrest, Induced; Hypothermia, Induced; Magnesium; Male; Metalloendopeptidases; Myocardial Contraction; Myocardial Reperfusion Injury; Potassium Chloride; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Sodium Chloride; Sulfonamides; Time Factors | 1997 |
Combined blockade of endothelin-1 and thromboxane A(2) receptors against postischaemic contractile dysfunction in rat hearts.
Topics: Adenosine Triphosphate; Animals; Blood Pressure; Bosentan; Coronary Circulation; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Phosphocreatine; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Ventricular Function, Left; Ventricular Pressure | 2001 |
Endothelin receptor blockade reduces ventricular dysfunction and injury after reoxygenation.
Topics: Animals; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Gene Expression; Infusions, Intravenous; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide Synthase; Receptors, Endothelin; RNA, Messenger; Sulfonamides; Swine; Ventricular Dysfunction | 2001 |
Role of endogenous endothelin on coronary reflow after cardioplegic arrest.
Topics: Animals; Bosentan; Chromatography, High Pressure Liquid; Coronary Circulation; Dioxoles; Endothelin Receptor Antagonists; Endothelins; Heart Arrest, Induced; Male; Myocardial Reperfusion Injury; Perfusion; Pyridines; Rats; Rats, Sprague-Dawley; Sulfonamides; Tetrazoles | 2001 |
Hyperglycemia exaggerates ischemia-reperfusion-induced cardiomyocyte injury: reversal with endothelin antagonism.
Topics: Antihypertensive Agents; Bosentan; Cells, Cultured; Diabetic Angiopathies; Endothelin Receptor Antagonists; Endothelin-1; Humans; Myocardial Reperfusion Injury; Peptides, Cyclic; Sulfonamides | 2002 |